FDA says Glaxo vaccine blocks cancer-causing virus

WASHINGTON — A vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer, the Food and Drug Administration said Friday.

In documents posted online, the FDA said Cervarix — Glaxo’s vaccine against human papilloma virus or HPV — successfully blocked the two most cancerous strains of the virus nearly 93 percent of the time.

The main study of the vaccine enrolled more than 18,000 women who either received Cervarix or a sham treatment. The FDA said the vaccine appears to fight the HPV virus for more than six years, based on company data. Side effects were minor, such as pain and swelling at the injection site.

The agency will ask a panel of vaccine experts next week whether Cervarix should be approved for girls and women ages 10 to 25. The FDA is not required to follow the group’s advice, though it usually does.

A positive review from the agency will clear the British drugmaker’s vaccine to compete in the U.S., though it could face an uphill battle against Merck’s blockbuster vaccine Gardasil, which has been on the market here since 2006.

Besides having a three-year head start, Gardasil also defends against two more HPV types that cause 90 percent of genital warts, something Cervarix does not target.

Cervarix already is approved in nearly 100 other countries, but has been delayed in the U.S. since 2007 when the FDA said it needed additional data.

Earlier studies of Cervarix showed a higher number of muscular and neurological problems among patients who used the vaccine compared with the alternate treatment.

The FDA said Friday it asked outside experts to examine more recent data from the company to see if Cervarix could have caused those problems.

“The conclusion in the case of each of these efforts was that the data are not sufficient to establish a link,” the agency said in its review.

The FDA said it would ask Glaxo to report any continuing problems in a follow-up study planned for after the vaccine’s launch.

About 6 million people in the U.S. each year contract HPV, which usually causes no symptoms and clears up by itself. While there are about 40 strains of the virus that are spread through sexual contact, only about 15 cause cancer in men and women.

Last year nearly 4,000 women died of cervical cancer.

“Protection against cervical cancer is a very important health need for girls and young women, and we believe Cervarix has an important role to play in addressing this,” said Glaxo spokeswoman Lisa Behrens.

Copyright © 2009 The Associated Press. All rights reserved.

by http://www.google.com/hostednews/ap/article/ALeqM5g1HxhLzEH0T9Qq5lHTSfL9FTanxAD9AGJSIG0

 

Ernie Harwell, the 91-year-old Hall of Fame broadcaster for the Detroit Tigers has inoperable cancer

Ernie Harwell, the 91-year-old Hall of Fame broadcaster for the Detroit Tigers, said Friday that he has inoperable cancer.

Harwell said he has a tumor near a bile duct. He says he knows he may go through some painful days but is in good spirits and appreciates the good wishes he has received from hundreds of fans.

Harwell spent 42 of his 55 years as a broadcaster calling Tigers games, from 1960 to 2002. He said he has been “flattered” to hear so many people tell him about the role his voice played in their lives.

“It’s a great honor to be part of the family like that,” Harwell said. “It was fun. You love these things. You can’t take them too seriously. . . . So-called fame is fleeting.”

Harwell was born Jan. 25, 1918, in Washington, Ga., and began his broadcasting career in 1940 as a sports commentator for WSB radio in Atlanta. He later broadcast for the Brooklyn Dodgers and was replaced by Vin Scully.

Etc.

Cleveland Indians center fielder Grady Sizemore will sit out the rest of the season because of soreness in his left elbow that will require arthroscopic surgery. . . . Chicago Cubs left fielder Alfonso Soriano is out indefinitely because of a sore left knee. Cubs Manager Lou Piniella said at some point the club will “revisit” the situation, but he’s not sure when. . . . New York Yankees closer Mariano Rivera, who is suffering from a sore left groin and has not pitched since Tuesday, will throw in the bullpen today and could be ready to return to the mound Sunday, Manager Joe Girardi said. . . . New York Mets pitcher Johan Santana returned to Citi Field three days after undergoing season-ending surgery to remove bone chips from his left elbow and said he felt better and was confident he would be ready for spring training next year.

news by http://www.latimes.com/sports/la-sp-bbnotes5-2009sep05,0,5292207.story